The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature.
Open accessAbstract
BACKGROUND: Despite renewed interest in studying the safety and efficacy of psychedelic-assisted psychotherapy for the treatment of psychological disorders, the enrollment of racially diverse participants and the unique presentation of psychopathology in this population has not been a focus of this potentially ground-breaking area of research. In 1993, the United States National Institutes of Health issued a mandate that funded research must include participants of color and proposals must include methods for achieving diverse samples. METHODS: A methodological search of psychedelic studies from 1993 to 2017 was conducted to evaluate ethnoracial differences in inclusion and effective methods of recruiting peopple of color. RESULTS: Of the 18 studies that met full criteria (n = 282 participants), 82.3% of the participants were non-Hispanic White, 2.5% were African-American, 2.1% were of Latino origin, 1.8% were of Asian origin, 4.6% were of indigenous origin, 4.6% were of mixed race, 1.8% identified their race as "other," and the ethnicity of 8.2% of participants was unknown. There were no significant differences in recruitment methodologies between those studies that had higher (> 20%) rates of inclusion. CONCLUSIONS: As minorities are greatly underrepresented in psychedelic medicine studies, reported treatment outcomes may not generalize to all ethnic and cultural groups. Inclusion of minorities in futures studies and improved recruitment strategies are necessary to better understand the efficacy of psychedelic-assisted psychotherapy in people of color and provide all with equal opportunities for involvement in this potentially promising treatment paradigm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“First, the success of allocation blinding was not assessed, and it is likely that the acute psychoactive effects of psilocybin produced some degree of functional unblinding that may have contributed to the observed effect in psilocybin-treated (psilocybin -niacin).”
From Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“First, the success of allocation blinding was not assessed, and it is likely that the acute psychoactive effects of psilocybin produced some degree of functional unblinding that may have contributed to the observed effect in psilocybin-treated (psilocybin -niacin).”
From Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial (2023) · cites this paper as [33]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391 · cited 1×
“Although several studies report similar lifetime prevalence rates of OCD between non-Hispanic Blacks and other ethnic groups [28, 30, 32], the diagnosis is often missed during structural clinical interviews, reducing enrollment in treatment trials [33–35].”
BackgroundRacial microaggressions in everyday life: Implications for clinical practice.
Sue, D. W., Capodilupo, C. M., Torino, G. C., Bucceri, J. M., Holder, A. M. B., Nadal, K. L., & Esquilin, M. (2007) · American Psychologist · doi:10.1037/0003-066x.62.4.271 · Cited by 5,569 · cited 1×
“A clinician of a race other than the client’s may dismiss the impact race-based trauma has had on the client’s mental health [76].”
BackgroundAntidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698 · cited 1×
“All but three studies [21, 65, 66] utilized more than one source of recruitment.”
BackgroundCarhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
Human hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203 · cited 4×
“, administration to physically-restrained subjects, sexual abuse between therapists and clients), major methodological flaws, and concerns over safety led to defunding of research and ultimately the scheduling of psychedelics as controlled substances [8, 9].”
BackgroundInfluentialPsilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151 · cited 1×
“Of the seven studies from the United States, all but one [64] were composed of majority White participants.”
BackgroundSue, S., Fujino, D. C., Hu, L.-T., & Takeuchi, D. T. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.59.4.533 · Cited by 970
Barriers to mental health treatment: results from the National Comorbidity Survey Replication
Mojtabai, R., Olfson, M., Sampson, N. A., Jin, R., Druss, B., Wang, P. S., Wells, K. B., Pincus, H. A., & Kessler, R. C. (2011) · Psychological Medicine · doi:10.1017/s0033291710002291 · Cited by 951 · cited 1×
“This may be due, in part, to long-standing social and economic barriers to psychological treatments for minorities [39, 40] and a shameful history of the medical establishment subjecting minorities to significant harm as a direct result of medical research participation [41].”
Background
Research works printed but not linked: 7
- Barton C. The elephant in the room: the need to address race in psychedelic research. MAPS Bull. 2017;27:1–3.
- Pierce C. Offensive Mechanisms. In: Barbour F, editor. The black seventies. Boston: Porter Sargent; 1970. p. 265–82.
- Williams MT, Chapman LK, Wong J, Turkheimer E. The role of ethnic identity in symptoms of anxiety and depression in African Americans. role Ethn. identity symptoms anxiety Depress. African Am. 2012;199(1):31–6.
- National Institutes of Health. Report of the advisory committee on research on women’s health. 2016;
- U.S. Department of Health and Human Services, Food and Drug Administration, Office of the Commissioner, Office of Minority Health, Office of Women’s Health, Center for Drug Evaluation and Research, et al. Collection of race and ethnicity data in clinical trials: Guidance for industry and Food and Drug Administration staff. 2016;
- United States Department of Health and Human Services U. Monitoring adherence to the NIH policy on the inclusion of women and minorities as subjects in clinical research; 2013. p. 145–60.
- Mendoza DB, Williams MT, Chapman KL, Powers M. Minority inclusion in randomized clinical trials of panic disorder. J Anxiety Disord. 2012;24(2):171-177. · DOI · Paper page
Cited by
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial
Raison, C. L., Sanacora, G., Woolley, J., Heinzerling, K., Dunlop, B. W., Brown, R. T., Kakar, R., Hassman, M., Trivedi, R. P., Robison, R., et al. (2023) · JAMA · doi:10.1001/jama.2023.14530 · Cited by 545
Davis, A. K., Barrett, F. S., & Griffiths, R. R. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.004 · Cited by 375
“Although our sample is consistent with prior studies of psychedelic users using similar recruitment procedures (Davis et al., 2018; Barret et al., 2016), similar to Michaels et al. (2018) we strongly encourage future researchers to continue efforts in recruiting a diverse sample.”
ResultAgin-Liebes, G. I., Malone, T., Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., Bossis, A. P., Grigsby, J., Fischer, S., & Ross, S. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119897615 · Cited by 360
“…psychedelicassisted therapies, minority groups are greatly underrepresented, and future investigators should make concerted efforts to address this issue by developing research-community collaborations to decrease prohibitive barriers to participation (George et al., 2019; Michaels et al., 2018).”
BackgroundLong-term effects of psychedelic drugs: A systematic review
Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K., Davoli, C. C., & Davis, A. K. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.03.017 · Cited by 257
George, J. R., Michaels, T. I., Sevelius, J., & Williams, M. T. (2019) · Journal of Psychedelic Studies · doi:10.1556/2054.2019.015 · Cited by 230
“…medicine were quite low; only 2.2% of participants were Black (participants who identify as being of African descent including but not limited to African Americans, Caribbean Blacks, etc.), 2.2% were of Latino origin, 1.5% of Asian origin, and 4.7% were indigenous (Michaels et al., 2018).”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Michaels, T. I., Purdon, J., Collins, A., & Williams, M. T.
- Affiliations
- University of Connecticut (US)
- Corresponding author
- Michaels, Timothy I.
- Venue
- BMC Psychiatry
- Published
- 2018-07-31
- Volume
- 18
- Issue
- 1
- Pages
- 245-245
- ISSN
- 1471-244X (ISSN-L)
- PMC
- PMC6069717
- OpenAlex
- W2887938296
- Semantic Scholar
- e560ffad0878b7a562aad2184ea8fe3bba74fb02
- Cited by
- 265
- References
- 81
- Citations by year
- 2026: 22 · 2025: 54 · 2024: 61 · 2023: 46 · 2022: 35 · 2021: 24 · 2020: 14 · 2019: 9
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- BMC Psychiatry (publishedVersion, cc-by)
- SSRN Electronic Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- psychedelic-assisted psychotherapy, people of color, racial and ethnic diversity, underrepresentation in clinical trials, participant recruitment strategies, indigenous peoples, Latino population, African American population
- MeSH terms
- Adult, Mental Disorders, Black or African American, Ethnicity, Female, Hallucinogens, Hispanic or Latino, Humans, Male, Minority Groups, Psychotherapy, Research Design, United States, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature. https://app.cochat.ai/papers/10.1186/s12888-018-1824-6
- The paper
- Michaels, T. I., Purdon, J., Collins, A., & Williams, M. T. (2018). Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature. BMC Psychiatry. https://doi.org/10.1186/s12888-018-1824-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.